Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of VeraCept vs ParaGard in Healthy Women
NCT03785366Phase 3Completed
- Sponsor
- Sebela Pharmaceuticals
- Start
- Dec 2018
- Primary completion
- Dec 2019
- Modality
- Device-based Delivery, DNA Intercalators/Alkylators, Covalent Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of miudella in pregnancy, sponsored by Sebela Pharmaceuticals. Started Dec 2018; status: completed.
02
Drugs
miudella
03
Conditions
pregnancy
Beyond the preview
Go deeper on NCT03785366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03785366.